NKMAX Trademark

Trademark Overview


On Thursday, November 11, 2021, a trademark application was filed for NKMAX with the United States Patent and Trademark Office. The USPTO has given the NKMAX trademark a serial number of 97121020. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by NKMAX CO., LTD.. The NKMAX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for animals for regulating the immune system and treating cancer; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of cells for regulating the immune system and treating cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune ...

Development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes; medical and pharmacological research services; medical research services; development of biotechnology products; biotechnological research; cell separation research services; technological research in the field of cell therapy, medicine, pharmacology, biotechnology
nkmax

General Information


Serial Number97121020
Word MarkNKMAX
Filing DateThursday, November 11, 2021
Status700 - REGISTERED
Status DateTuesday, August 22, 2023
Registration Number7146622
Registration DateTuesday, August 22, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for animals for regulating the immune system and treating cancer; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of cells for regulating the immune system and treating cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of immune system related diseases and disorders
Pseudo MarkNATURAL KILLER MAXIMIZING
Goods and ServicesDevelopment of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes; medical and pharmacological research services; medical research services; development of biotechnology products; biotechnological research; cell separation research services; technological research in the field of cell therapy, medicine, pharmacology, biotechnology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 18, 2021
Primary Code005
First Use Anywhere DateMonday, August 5, 2019
First Use In Commerce DateMonday, August 5, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 18, 2021
Primary Code042
First Use Anywhere DateTuesday, March 5, 2019
First Use In Commerce DateTuesday, March 5, 2019

Trademark Owner History


Party NameNKMAX CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGyeonggi-do 13605
KR

Party NameNKMAX CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGyeonggi-do 13605
KR

Party NameNKMAX CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGyeonggi-do 13605
KR

Trademark Events


Event DateEvent Description
Tuesday, August 22, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 22, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, July 19, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 18, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 17, 2023ASSIGNED TO EXAMINER
Wednesday, May 17, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 27, 2023USE AMENDMENT FILED
Wednesday, May 17, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 27, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 25, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, August 25, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 25, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, August 25, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, August 22, 2022ASSIGNED TO EXAMINER
Thursday, November 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 15, 2021NEW APPLICATION ENTERED